Company profile: Intas is a leading, vertically integrated global pharmaceutical formulation development, manufacturing and marketing company headquartered in India.Intas's success and incessant growth lies in effective execution of its strategic planning in the field of manufacturing, Research & Development, Biotechnology and Global Operations over the last three decades. Today, Intas is more than $500 million organization with CAGR- 35% over the last 4 years and is ranked as the 12th largest pharmaceutical company in the domestic market. [As per IMS Health India, Secondary Stockist Audit (SSA), February 2012]In Indian market, Intas is one of the leading players in the field of chronic therapies with strong presence in Neurology (CNS), Cardiology (CVS), Diabetology and Gastroenterology & Pain Management. Recently, Intas has extended its presence into other therapeutic areas such as Gynecology, Infertility and Respiratory care.Besides domestic dominance, Intas has significant international presence in over 50 countries worldwide and has made successful forays into strategic alliances & marketing tie-ups with Global Pharma companies across the world predominantly in North America, Europe & Latin America.Intas Biopharmaceuticals Limited, a fully owned subsidiary of Intas Pharmaceuticals Limited has made substantial investments in the Development, Manufacturing and Marketing of Biotech products in areas of chronic therapies including Oncology and Nephrology.Continual R & D initiatives have further strengthened our niche products and allow us to offer complex products in India and International markets. New Drug Delivery System- NDDS is one such outcome of these initiatives. Having Commercialized in India- these novel lipid based pharmaceutical formulations will be extended to the International markets soon.Intas has made strategic investments in ten manufacturing facilities across the globe having accreditations from leading international Regulatory bodies including U.S. Food and Drug Administration (FDA).